Cerebral white matter lesions predict both ischemic strokes and myocardial infarctions in patients with established atherosclerotic disease

Atherosclerosis

Volumn 186, Issue 1, 2006, Pages 166-172

  Gerdes, Victor E A ^a,b   Kwa, Vincent I H ^b   ten Cate, Hugo ^c   Brandjes, Dees P M ^b   Büller, Harry R ^a   Stam, Jan ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cerebrovascular disorders; Myocardial infarction; Peripheral vascular disease; Stroke; White matter lesions

Indexed keywords

ADULT; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BRAIN DAMAGE; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REGISTER; WHITE MATTER;

AGED; ATHEROSCLEROSIS; BRAIN; CEREBROVASCULAR ACCIDENT; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33645875885     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.07.008     Document Type: Article

References (29)

1. Pantoni L., and Garcia J. Pathogenesis of leukoaraiosis. A review. Stroke 28 (1997) 652-659
2. Breteler M., van Swieten J., Bots M., et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam study. Neurology 44 (1994) 1246-1252
3. Baloh R., Yue Q., Socotch T., et al. White matter lesions and disequilebrium in older people. I. Case-control comparison. Arch Neurol 52 (1995) 970-974
4. Urban P., Wicht S., Vukurevic G., et al. Dysarthria in acute ischemic stroke: lesion topography, clinicoradiologic correlation, and etiology. Neurology 56 (2001) 1021-1027
5. Bots M., van Swieten J., Breteler M., et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam study. Lancet 341 (1993) 1232-1237
6. Longstreth Jr. W., Manolio T., Arnold A., et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The cardiovascular health study. Stroke 27 (1996) 1274-1282
7. Zunker P., Schick A., Buschmann H., et al. Hyperinsulinism and cerebral microangiopathy. Stroke 27 (1996) 219-223
8. Fassbender K., Bertsch T., Mielke O., et al. Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 30 (1999) 1647-1650
9. Catto A., Carter A., Barrett J., et al. Von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality. Thromb Haemostasis 77 (1997) 1104-1108
10. Vermeer S., van Dijk E., Koudstaal P., et al. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol 51 (2002) 285-289
11. Shimada K., Kawamoto A., Matsubayashi K., et al. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 10 (1992) 875-878
12. Toghi H., Chiba K., and Kimura M. Twenty-four-hour variation of blood pressure in vascular dementia of the Binswanger type. Stroke 22 (1991) 603-608
13. Schmidt R., Schmidt H., Fazekas F., et al. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian stroke prevention study. Stroke 28 (1997) 951-956
14. Schmidt R., Schmidt H., Fazekas F., et al. Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small-vessel disease-related cerebral abnormalities. Hypertension 38 (2001) 110-115
15. Schmidt R., Schmidt H., Fazekas F., et al. MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms: three-year follow-up of the austrian stroke prevention study. Arterioscl Thromb Vasc Biol 20 (2000) 1811-1816
16. van Swieten J., Kappelle L., Algra A., et al. Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Dutch TIA Trial Study Group. Ann Neurol 32 (1992) 177-183
17. Wong T., Klein R., Sharrett A., et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 288 (2002) 67-74
18. Vermeer S., Hollander M., van Dijk E., et al. Silent brain infarcts and white matter lesions increase stroke risk in the general population: The Rotterdam Scan Study. Stroke 34 (2003) 1126-1129
19. de Leeuw F., De Groot J., Oudkerk M., et al. Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly. Stroke 31 (2000) 425-429
20. de Leeuw F., de Groot J., Bots M., et al. Carotid atherosclerosis and cerebral white matter lesions in a population based magnetic resonance imaging study. J Neurol 247 (2000) 291-296
21. Fazekas F., Chawluk J., Alavi A., et al. MR Signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol 149 (1987) 351-356
22. Kwa VIH, Franke C., Verbeeten B., et al. Silent intracerebral hemorrhages in patients with ischemic stroke. Ann Neurol 44 (1998) 372-377
23. Scheltens P., Barkhof F., Leys D., et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J Neurol Sci 114 (1993) 7-12
24. Lammie G., Brannan F., Slattery J., et al. Nonhypertensive cerebral small-vessel disease. An autopsy study. Stroke 28 (1997) 2222-2229
25. de Leeuw F., de Groot J., Oudkerk M., et al. Atrial fibrillation and the risk of cerebral white matter lesions. Neurology 54 (2000) 1795-1801
26. Bakker S., de Leeuw F., de Groot J., et al. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology 52 (1999) 578-583
27. de Leeuw F., de Kleine M., Frijns C., et al. Endothelial cell activation is associated with cerebral white matter lesions in patients with cerebrovascular disease. Ann NY Acad Sci 977 (2002) 306-314
28. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., and Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 342 (2000) 145-153
29. O'Leary D., and Polak J.F. Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol 90 (2002) 18-21